Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2004-10-21
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare the efficacy of
metformin and repaglinide used alone or combined administered as initial treatment in
subjects with type 2 diabetes in which diet and exercise have failed.